UB
IPXL

UMB Bank’s Impax Laboratories, Inc. IPXL Stock Holding History

UMB Bank’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,600
Closed -$147K – 347
2017
Q1 		$147K Hold
11,600
– – 0.01% 330
2016
Q4 		$154K Hold
11,600
– – 0.01% 325
2016
Q3 		$275K Buy
11,600
+3,400
+41% +$91.4K 0.01% 304
2016
Q2 		$236K Hold
8,200
– – 0.01% 314
2016
Q1 		$263K Hold
8,200
– – 0.01% 306
2015
Q4 		$351K Hold
8,200
– – 0.02% 271
2015
Q3 		$289K Hold
8,200
– – 0.02% 245
2015
Q2 		$377 Buy
+8,200
New +$389K 0.02% 238

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UMB Bank's IPXL Position: Q2 2017 in Review

UMB Bank sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 11,600 shares — an estimated $147K sold.

UMB Bank first reported a position in IPXL in Q2 2015 and held it in 8 quarters. The position peaked at $351K in Q4 2015. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

  • UMB Bank reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
  • UMB Bank sold 11,600 Impax Laboratories, Inc. shares in Q2 2017, an estimated $147K.
  • UMB Bank first reported a position in Impax Laboratories, Inc. in Q2 2015 and held it in 8 quarters.
  • UMB Bank's Impax Laboratories, Inc. position peaked at $351K in Q4 2015.
  • 172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on UMB Bank's 13F filing for Q2 2017, filed 2 Aug 2017.